Neuropsychiatric symptoms (NPS) are a common aspect of Alzheimer’s disease (AD). Multiple studies have investigated its brain correlates, but it still remains unclear how they relate with brain atrophy in mild cognitive impairment (MCI).
Objective:
Our objective was to investigate brain volume in MCI patients as a function of NPS.
Methods:
We measured grey matter volume, neuropsychological status and NPS (Neuropsychiatric Inventory, NPI), in a sample of 81 MCI patients (43 females). Participants were divided in groups depending on presence (NPS+) or absence (NPS–) of NPS and on type of NPS.
Results:
We found lower volume of left temporal pole in patients with depression compared to NPS– (p = 0.012), and in patients with agitation compared to NPS– in the right middle occipital gyrus (p = 0.003). We also found a significant correlation between volume of left temporal pole and MMSE (r (78) = 0.232, p = 0.019). Finally, NPS+ presented lower cross-sectional cognitive level than NPS– (t (79) = 1.79, p = 0.038), and faster cognitive decline (t (48) = –1.74, p = 0.044).
Conclusions:
Our results support the colocalization of structural damage as a possible mechanism underlying the relationship between MCI and depression and provide novel evidence regarding agitation. Moreover, our longitudinal evidence highlights the relevance of an adequate identification of NPS in MCI patients to identify those at risk of faster cognitive decline.
McKhannGM, KnopmanDS, ChertkowH, HymanBT, JackCR, KawasCH, KlunkWE, KoroshetzWJ, ManlyJJ, MayeuxR, MohsRC, MorrisJC, RossorMN, ScheltensP, CarrilloMC, ThiesB, WeintraubS, PhelpsCH (2011) The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement7, 263–269.
DuboisB, VillainN, FrisoniGB, RabinoviciGD, SabbaghM, CappaS, BejaninA, BomboisS, EpelbaumS, TeichmannM, HabertMO, NordbergA, BlennowK, GalaskoD, SternY, RoweCC, SallowayS, SchneiderLS, CummingsJL, FeldmanHH (2021) Clinical diagnosis of Alzheimer’s disease: Recommendations of the International Working Group. Lancet Neurol20, 484–496.
4.
BoublayN, SchottAM, Krolak-SalmonP (2016) Neuroimaging correlates of neuropsychiatric symptoms in Alzheimer’s disease: A review of 20 years of research. Eur J Neurol23, 1500–1509.
5.
MartinE, VelayudhanL (2020) Neuropsychiatric symptoms in mild cognitive impairment: A literature review. Dement Geriatr Cogn Disord49, 146–155.
6.
SiafarikasN, SelbaekG, FladbyT, Šaltyte BenthJ, AuningE, AarslandD (2018) Frequency and subgroups of neuropsychiatric symptoms in mild cognitive impairment and different stages of dementia in Alzheimer’s disease. Int Psychogeriatr30, 103–113.
7.
GedaYE, RobertsRO, KnopmanDS, PetersenRC, ChristiansonTJH, PankratzVS, SmithGE, BoeveBF, IvnikRJ, TangalosEG, RoccaWA (2008) Prevalence of neuropsychiatric symptoms in mild cognitive impairment and normal cognitive aging: Population-based study. Arch Gen Psychiatry65, 1193–1198.
8.
AaltenP, VerheyFRJ, BozikiM, BullockR, ByrneEJ, CamusV, CaputoM, CollinsD, De DeynPP, ElinaK, FrisoniG, GirtlerN, HolmesC, HurtC, MarriottA, MecocciP, NobiliF, OussetPJ, ReynishE, SalmonE, TsolakiM, VellasB, RobertPH (2007) Neuropsychiatric syndromes in dementia. Results from the European Alzheimer Disease Consortium: Part I. Dement Geriatr Cogn Disord24, 457–463.
9.
MahL, BinnsMA, SteffensDC (2015) Anxiety symptoms in amnestic mild cognitive impairment are associated with medial temporal atrophy and predict conversion to Alzheimer’s disease. Am J Geriatr Psychiatry23, 466.
10.
RobertoN, PortellaMJ, MarquiéM, AlegretM, HernándezI, MauleónA, Rosende-RocaM, AbdelnourC, de AntonioEE, GilS, TartariJP, VargasL, EspinosaA, OrtegaG, Pérez-CordónA, SanabriaÁ, OrellanaA, de RojasI, Moreno-GrauS, MontrrealL, Alarcón-MartínE, RuízA, TárragaL, BoadaM, ValeroS (2021) Neuropsychiatric profiles and conversion to dementia in mild cognitive impairment, a latent class analysis. Sci Rep11, 6448.
11.
SugarmanMA, AloscoML, TripodisY, SteinbergEG, SternRA (2018) Neuropsychiatric symptoms and the diagnostic stability of mild cognitive impairment. J Alzheimers Dis62, 1841.
12.
RuthirakuhanM, HerrmannN, VieiraD, GallagherD, LanctôtKL (2019) The roles of apathy and depression in predicting Alzheimer disease: A longitudinal analysis in older adults with mild cognitive impairment. Am J Geriatr Psychiatry27, 873.
13.
MoonB, KimS, ParkYH, LimJS, YounYC, KimSY, JangJW (2017) Depressive symptoms are associated with progression to dementia in patients with amyloid-positive mild cognitive impairment. J Alzheimers Dis58, 1255–1264.
IsmailZ, SmithEE, GedaY, SultzerD, BrodatyH, SmithG, Agüera-OrtizL, SweetR, MillerD, LyketsosCG (2016) Neuropsychiatric symptoms as early manifestations of emergent dementia: Provisional diagnostic criteria for mild behavioral impairment. Alzheimers Dement12, 195–202.
19.
JinP, XuJ, LiaoZ, ZhangY, WangY, SunW, YuE (2023) A review of current evidence for mild behavioral impairment as an early potential novel marker of Alzheimer’s disease. Front Psychiatry14, 1099333.
20.
ChenY, DangM, ZhangZ (2021) Brain mechanisms underlying neuropsychiatric symptoms in Alzheimer’s disease: A systematic review of symptom-general and – specific lesion patterns. Mol Neurodegener16, 38.
21.
SiafarikasN, AlnæsD, Monereo-SanchezJ, LundMJ, SelbaekG, Stylianou-KorsnesM, PerssonK, BarcaML, AlmdahlIS, FladbyT, AarslandD, AndreassenOA, WestlyeLT (2021) Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment and Alzheimer’s disease with dementia. Int Psychogeriatr33, 1217–1228.
22.
TrzepaczPT, YuP, BhamidipatiPK, WillisB, ForresterT, TabasL, SchwarzAJ, SaykinAJ (2013) Frontolimbic atrophy is associated with agitation and aggression in mild cognitive impairment and Alzheimer’s disease. Alzheimers Dement9, S95.
23.
DuY, YanF, ZhaoL, FangY, QiuQ, WeiW, WangJ, TangY, LinX, LiX (2022) Depression symptoms moderate the relationship between gray matter volumes and cognitive function in patients with mild cognitive impairment. J Psychiatr Res151, 516–522.
24.
ZahodneLB, GongvatanaA, CohenRA, OttBR, TremontG (2013) Are apathy and depression independently associated with longitudinal trajectories of cortical atrophy in mild cognitive impairment?Am J Geriatr Psychiatry21, 1098–1106.
25.
DonovanNJ, WadsworthLP, LoriusN, LocascioJJ, RentzDM, JohnsonKA, SperlingRA, MarshallGA (2014) Regional cortical thinning predicts worsening apathy and hallucinations across the Alzheimer disease spectrum. Am J Geriatr Psychiatry22, 1168–1179.
26.
MorinJ-F, MouihaA, PietrantonioS, DuchesneS, HudonC (2012) Structural neuroimaging of concomitant depressive symptoms in amnestic mild cognitive impairment: A pilot study. Dement Geriatr Cogn Dis Extra2, 573–588.
27.
XieC, LiW, ChenG, Douglas WardB, FranczakMB, JonesJL, AntuonoPG, LiSJ, GoveasJS (2012) The co-existence of geriatric depression and amnestic mild cognitive impairment detrimentally affect gray matter volumes: Voxel-based morphometry study. Behav Brain Res235, 244–250.
28.
CummingsJL (1997) The Neuropsychiatric Inventory: Assessing psychopathology in dementia patients. Neurology48(5 Suppl 6), S10–S16.
29.
LyketsosCG, LopezO, JonesB, FitzpatrickAL, BreitnerJ, DekoskyS (2002) Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: Results from the cardiovascular health study. JAMA288, 1475–1483.
30.
AaltenP, De VugtME, LousbergR, KortenE, JaspersN, SendenB, JollesJ, VerheyFRJ (2003) Behavioral problems indementia: A factor analysis of the neuropsychiatric inventory. Dement Geriatr Cogn Disord15, 99–105.
31.
LoTWB, KaramehWK, BarfettJJ, FornazzariLR, MunozDG, SchweizerTA, FischerCE (2020) Association between neuropsychiatric symptom trajectory and conversion to Alzheimer disease. Alzheimer Dis Assoc Disord34, 141–147.
32.
SerranoC, AllegriRF, DrakeM, ButmanJ, HarrisP, NagleC, RanalliC (2001) [A shortened form of the Spanish Boston naming test: A useful tool for the diagnosis of Alzheimer’s disease]. Rev Neurol33, 624–627.
LoboA, SazP, MarcosG (2002), MMSE: Mini-Mental State Exam (in Spanish).
35.
PfefferRI, KurosakiTT, HarrahCH, ChanceJM, FilosS (1982) Measurement of functional activities in older adults in the community. J Gerontol37, 323–329.
36.
Vilalta-FranchJ, Lozano-GallegoM, Hernández-FerrándizM, Llinàs-ReglàJ, López-PousaS, LópezOL (1999) [The Neuropsychiatric Inventory. Psychometric properties of its adaptation into Spanish]. Rev Neurol29, 15–19.
37.
CummingsJ (2020) The Neuropsychiatric Inventory: Development and applications. J Geriatr Psychiatry Neurol33, 73–84.
38.
HuX, MeiberthD, NewportB, JessenF (2015) Anatomical correlates of the neuropsychiatric symptoms in Alzheimer’s disease. Curr Alzheimer Res12, 266–277.
39.
YuSY, ZhuWL, GuoP, LiSW, LiuYO, LianTH, DingDY, LiDN, LiLX, LiuL, ZhaoH, ZuoLJ, HuY, YuQJ, JinZ, WangRD, GaoJH, ZhuRY, WangXM, ZhangW (2020) Clinical features and brain structural changes in magnetic resonance imaging in Alzheimer’s disease patients with apathy. Aging (Albany NY)12, 19083–19094.
40.
GreenS, Lambon RalphMA, MollJ, ZakrzewskiJ, DeakinJFW, GrafmanJ, ZahnR (2013) The neural basis of conceptual-emotional integration and its role in major depressive disorder. Soc Neurosci8, 417–433.
41.
ZahnR, WeingartnerJH, BasilioR, BadoP, MattosP, SatoJR, de Oliveira-SouzaR, FontenelleLF, YoungAH, MollJ (2019) Blame-rebalance fMRI neurofeedback in major depressive disorder: A randomised proof-of-concept trial. Neuroimage Clin24, 101992.
42.
OtsukaY, YumotoT, IhoriyaH, MatsumotoN, SatoK, AbeK, NaitoH, NakaoA (2018) Acute agitation as an initial manifestation of Neuro-Behçet’s disease. Case Rep Emerg Med2018, 5437027.
43.
MallerJJ, AndersonRJ, ThomsonRH, DaskalakisZJ, RosenfeldJV, FitzgeraldPB (2017) Occipital bending in schizophrenia. Aust N Z J Psychiatry51, 32–41.
44.
Fernandez-MartinezM, MolanoA, CastroJ, ZarranzJ (2010) Prevalence of neuropsychiatric symptoms in mild cognitive impairment and Alzheimer’s disease, and its relationship with cognitive impairment. Curr Alzheimer Res7, 517–526.
45.
ArnoldSE, HymanBT, Van HoesenGW (1994) Neuropathologic changes of the temporal pole in Alzheimer’s disease and Pick’s disease. Arch Neurol51, 145–150.
46.
HänggiJ, StrefferJ, JänckeL, HockC (2011) Volumes of lateral temporal and parietal structures distinguish between healthy aging, mild cognitive impairment, and Alzheimer’s disease. J Alzheimers Dis26, 719–734.
47.
NagS, YuL, BoylePA, LeurgansSE, BennettDA, SchneiderJA (2018) TDP-43 pathology in anterior temporal pole cortex in aging and Alzheimer’s disease. Acta Neuropathol Commun6, 33.
48.
ZackováML, JániMM, BrázdilM, NikolovaYS, MarečkováK (2021) Cognitive impairment and depression: Meta-analysis of structural magnetic resonance imaging studies. Neuroimage (Amst)32, 102830.
49.
GedaYE, SchneiderLS, GitlinLN, MillerDS, SmithGS, BellJ, EvansJ, LeeM, PorsteinssonA, LanctôtKL, RosenbergPB, SultzerDL, FrancisPT, BrodatyH, PadalaPP, OnyikeCU, OrtizLA, Ancoli-IsraelS, BliwiseDL, MartinJL, VitielloMV, YaffeK, ZeePC, HerrmannN, SweetRA, BallardC, KhinNA, AlfaroC, MurrayPS, SchultzS, LyketsosCG (2013) Neuropsychiatric symptoms in Alzheimer’s disease: Past progress and anticipation of the future. Alzheimers Dement9, 602–608.
50.
TagaiK, NagataT, ShinagawaS, ShigetaM (2020) Anosognosia in patients with Alzheimer’s disease: Current perspectives. Psychogeriatrics20, 345–352.
51.
RubyP, SchmidtC, HoggeM, D’ArgembeauA, ColletteF, SalmonE (2007) Social mind representation: Where does it fail in frontotemporal dementia?J Cogn Neurosci19, 671–683.
52.
OttBR, NotoRB, FogelBS (1996) Apathy and loss of insight in Alzheimer’s disease: A SPECT imaging study. J Neuropsychiatry Clin Neurosci8, 41–46.
53.
CacciamaniF, HouotM, GagliardiG, DuboisB, SikkesS, Sánchez-BenavidesG, DenicolòE, MolinuevoJL, VanniniP, EpelbaumS (2021) Awareness of cognitive decline in patients with Alzheimer’s disease: A systematic review and meta-analysis. Front Aging Neurosci13, 697234.
54.
EnacheD, CavallinL, LindbergO, FarahmandB, KrambergerMG, WestmanE, JelicV, EriksdotterM, BallardC, WinbladB, WahlundLO, AarslandD (2015) Medial temporal lobe atrophy and depressive symptoms in elderly patients with and without Alzheimer disease. J Geriatr Psychiatry Neurol28, 40–48.
55.
AuningE, SelnesP, GrambaiteR, Šaltyte BenthJ, HaramA, Løvli StavA, BjørnerudA, HessenE, HolPK, Muftuler løndalenA, FladbyT, AarslandD (2015) Neurobiological correlates of depressive symptoms in people with subjective and mild cognitive impairment. Acta Psychiatr Scand131, 139–147.
56.
ŠimićG, Babić LekoM, WrayS, HarringtonCR, DelalleI, Jovanov-MiloševićN, BažadonaD, BuéeL, de SilvaR, Di GiovanniG, WischikCM, HofPR (2017) Monoaminergic neuropathology in Alzheimer’s disease. Prog Neurobiol151, 101–138.
57.
EhrenbergAJ, SuemotoCK, França ResendeE de P, PetersenC, LeiteREP, RodriguezRD, Ferretti-Rebustini RE deL, YouM, OhJ, NitriniR, PasqualucciCA, Jacob-FilhoW, KramerJH, GatchelJR, GrinbergLT (2018) Neuropathologic correlates of psychiatric symptoms in Alzheimer’s disease. J Alzheimers Dis66, 115–126.
58.
SmithGS, ProtasH, KuwabaraH, SavonenkoA, NasseryN, GouldNF, KrautM, AvramopoulosD, HoltD, DannalsRF, NandiA, SuY, ReimanEM, ChenK (2023) Molecular imaging of the association between serotonin degeneration and beta-amyloid deposition in mild cognitive impairment. Neuroimage Clin37, 103322.
59.
YaffeK, PetersenRC, LindquistK, KramerJ, MillerB (2006) Subtype of mild cognitive impairment and progression to dementia and death. Dement Geriatr Cogn Disord22, 312–319.
60.
JungwirthS, ZehetmayerS, HinterbergerM, TraglKH, FischerP (2012) The validity of amnestic MCI and non-amnestic MCI at age 75 in the prediction of Alzheimer’s dementia and vascular dementia. Int Psychogeriatr24, 959–966.
61.
CarandiniT, ArighiA, SacchiL, FumagalliGG, PietroboniAM, GhezziL, ColombiA, ScarioniM, FenoglioC, De RizMA, MarottaG, ScarpiniE, GalimbertiD (2019) Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: From biological biomarkers to clinical syndromes. Alzheimers Res Ther11, 84.
